SEROQUEL XR, pronounced SER-O-KWELL X-R, is FDA approved to treat major depressive disorder as add-on therapy to an antidepressant medication. In clinical trials, SEROQUEL XR was proven to help treat unresolved symptoms of depression as add-on therapy to an antidepressant medication. Unresolved symptoms are those that remain despite initial treatment with an antidepressant after at least 6 weeks. Adding SEROQUEL XR to your current antidepressant may help further improve your unresolved symptoms of depression.
No comments:
Post a Comment